Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ERNA
ERNA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ERNA News
Ernexa's Innovative Advances in Ovarian Cancer Treatment
May 20 2026
Newsfilter
Ernexa Therapeutics Reports Significant Loss Narrowing in Q1
May 12 2026
stocktwits
Ernexa's Innovative Advances in Ovarian Cancer Treatment
May 11 2026
Newsfilter
Ernexa Therapeutics Exceeds Expectations with Promising Therapy Results
May 06 2026
stocktwits
Ernexa Therapeutics Reports Breakthrough in Cancer Treatment
May 06 2026
Newsfilter
Ernexa Therapeutics to Implement 1-for-25 Reverse Stock Split
Apr 30 2026
seekingalpha
Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split
Apr 30 2026
seekingalpha
Ernexa Implements 1-for-25 Reverse Stock Split
Apr 30 2026
Newsfilter
Ernexa Therapeutics Hosts Investor Webcast
Feb 20 2026
Newsfilter
ZIM Integrated Shipping Shares Surge 38.1% in Pre-Market Trading
Feb 17 2026
Benzinga
U.S. Stocks Rise, AutoNation Shares Surge
Feb 06 2026
Benzinga
U.S. Stocks Rise in Morning Trading, Dow Jones Up Over 600 Points
Feb 06 2026
Benzinga
Ernexa Therapeutics Prices Public Offering at $0.50 per Share
Feb 06 2026
Newsfilter
Ernexa Therapeutics Advances Cell Therapy for Cancer Treatment
Feb 03 2026
Newsfilter
Penguin Solutions Reports Q1 Earnings of $0.49, Shares Up 5.3%
Jan 07 2026
Benzinga
Ernexa Therapeutics Targets 2026 for First-in-Human Ovarian Cancer Trial
Jan 06 2026
Globenewswire
Show More News
